ReviewCells2024

Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine.

Saif Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.